✦ LIBER ✦

Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix®): Results of two randomized trials

✍ Scribed by Wayde M. Weston; Leonard R. Friedland; Xiangfeng Wu; Barbara Howe

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Immunogenicity and safety of a tetanus t

✍ Mark Blatter; Leonard R. Friedland; Wayde M. Weston; Ping Li; Barbara Howe 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 504 KB

Adverse Effects of Tetanus Toxoid, Reduc

✍ Sung-Hsi Wei; Yen-Nan Chao; Song-En Huang; Tsuey-Feng Lee; Luan-Yin Chang 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 224 KB

Persistence of antibodies 3 years after

✍ Wayde Weston; Marc Messier; Leonard R. Friedland; Xiangfeng Wu; Barbara Howe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Adverse events after Tetanus Toxoid, Red

✍ Pedro L. Moro; Xin Yue; Paige Lewis; Penina Haber; Karen Broder 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 201 KB

An adolescent–adult formulation tetanus

✍ Joanne M. Langley; Gerald Predy; R. Guasparini; Barbara Law; Francisco Diaz-Mito 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 154 KB

A randomized trial of two acellular pert

✍ Fiona M Turnbull; Timothy C Heath; Bin B Jalaludin; Margaret A Burgess; Anya C R 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 606 KB